VAERS Explorer
Back to explore

Report #2880778

Received Jan 14, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
0.2 yrs
State
MI
Recovered
Unknown
Vaccinated
Jan 5, 2026
Onset
Jan 5, 2026
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.1Z005765IM / RL
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.UNKZ005765—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

an 8-week-old patient received CAPVAXIVE due to a human error.; This spontaneous report was received from an Administrator / Supervisor (an office manager in a physician's office) and refers to a(n) 8-week-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 05-Jan-2026, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE), 0.5 mL, total (0.5ml/once), lot #Z005765, expiration date: 23-Nov-2026, administered for prophylaxis (route and anatomical site were not reported). This 8-week-old patient received Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) due to a human error.